US Patent Issued to CRINETICS PHARMACEUTICALS on April 14 for "Nonpeptide somatostatin type 5 receptor agonists and uses thereof" (California Inventors)

ALEXANDRIA, Va., April 15 -- United States Patent no. 12,600,709, issued on April 14, was assigned to CRINETICS PHARMACEUTICALS INC. (San Diego).

"Nonpeptide somatostatin type 5 receptor agonists and uses thereof" was invented by Jian Zhao (San Diego), Yunfei Zhu (San Diego), Shimiao Wang (San Diego), Mi Chen (San Diego) and Joseph Pontillo (San Diego).

According to the abstract* released by the U.S. Patent & Trademark Office: "Described herein are compounds that are somatostatin modulators, methods of making such compounds, pharmaceutical compositions and medicaments comprising such compounds, and methods of using such compounds in the treatment of conditions, diseases, or disorders that would benefit from modulation of somatostatin acti...